Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Equity (2017 - 2025)

Puma Biotechnology's Return on Equity history spans 9 years, with the latest figure at 0.28% for Q3 2025.

  • For Q3 2025, Return on Equity fell 11.0% year-over-year to 0.28%; the TTM value through Sep 2025 reached 0.28%, down 11.0%, while the annual FY2024 figure was 0.33%, 25.0% down from the prior year.
  • Return on Equity reached 0.28% in Q3 2025 per PBYI's latest filing, down from 0.42% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.34% in Q4 2021 to a low of 20.84% in Q1 2022.
  • Average Return on Equity over 5 years is 1.53%, with a median of 0.24% recorded in 2023.
  • Peak YoY movement for Return on Equity: crashed -1573bps in 2022, then soared 2104bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 4.34% in 2021, then crashed by -89bps to 0.47% in 2022, then dropped by 0bps to 0.47% in 2023, then plummeted by -37bps to 0.29% in 2024, then dropped by -5bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Return on Equity are 0.28% (Q3 2025), 0.42% (Q2 2025), and 0.34% (Q1 2025).